NCT00618254View on ClinicalTrials.gov

A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
NauseaVomiting
Interventions
DRUG

Granisetron

Trial Locations (1)

68502

MDS Pharma Services, Lincoln

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00618254 - A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter